rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    LENZ
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      LENZ Therapeutics: Don't Be Tempted With This Value Trap

      LENZ Therapeutics faces mounting cash burn, imminent dilution risk, and severe operational cuts, with no R&D pipeline. I rate LENZ stock as Sell. Read my analysis.

      Nov 13Seeking AlphaLENZ
      LENZ Therapeutics (LENZ) Stock Fair Value Moves Lower As Analysts Split On VIZZ
      Nov 4Yahoo FinanceLENZ
      12 Health Care Stocks Moving In Tuesday's Intraday Session
      Nov 3BenzingaCRISLENZ
      RA Capital Management sells $9.13M in Lenz Therapeutics shares
      Nov 2Investing.comLENZ
      Lenz Therapeutics stock price target cut to $16 by H.C. Wainwright
      Oct 30Investing.comLENZ
      LENZ Therapeutics (LENZ) Stock Rallies As Q3 Results Expose Cash Burn
      Oct 30Yahoo FinanceLENZ
      LENZ Therapeutics Inc (LENZ) Q3 2026 Earnings Call Highlights: Revenue Jumps 50% as ...
      Oct 29Yahoo FinanceLENZ
      LENZ Therapeutics Announces Major Restructuring and CEO Transition

      Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

      Oct 29The Globe and MailLENZ
      LENZ Therapeutics Q3 Earnings Call Highlights
      Oct 29Yahoo FinanceLENZ
      Earnings call transcript: LENZ Therapeutics misses Q3 2026 estimates as VIZZ grows
      Oct 29Investing.comLENZ
      LENZ Therapeutics Q3 2026 Earnings Call Transcript
      Oct 29BenzingaLENZ
      LENZ Therapeutics earnings missed by $0.08, revenue fell short of estimates
      Oct 28Investing.comLENZ
      LENZ Therapeutics reports 50% Q3 sales growth, CEO to step down
      Oct 28Investing.comLENZ
      LENZ Therapeutics, Inc. (LENZ) Reports Q3 Loss, Misses Revenue Estimates
      Oct 28Yahoo FinanceLENZ
      LENZ Therapeutics Reports Third Quarter 2026 Financial Results, Announces Strategic Consumer Marketing Focused Reorganization and CEO Succession
      Oct 28Yahoo FinanceLENZ
      LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026
      Oct 22Yahoo FinanceLENZ
      LENZ Therapeutics (LENZ) Stock Fair Value Falls After Analysts Cut VIZZ Launch Expectations
      Oct 21Yahoo FinanceLENZ
      Piper Sandler Keeps Their Hold Rating on LENZ Therapeutics (LENZ)

      Detailed price information for Lenz Therapeutics Inc (LENZ-Q) from The Globe and Mail including charting and trades.

      Oct 20The Globe and MailLENZ
      LENZ Therapeutics: Below Cash For A Reason (NASDAQ:LENZ)
      Sep 25Seeking AlphaLENZ
      Presbyopia Market Expected to Transform with Next-Generation Therapies and Strong Growth Through 2036 – DelveInsight | AbbVie, Orasis Pharma, Eyenovia, Glaukos Corp., Ocuphire Pharma, Novartis
      Sep 25BarchartLENZOCUP
      Gene editing stocks fall after Anthropic’s CRISPR-like discovery
      Sep 23Seeking AlphaCRSPLENZNTLA
      LENZ Therapeutics: Still Speculative But Priced For Disasters (NASDAQ:LENZ)
      Sep 4Seeking AlphaLENZ
      Short Interest Alert: Most and least shorted sub-$2B healthcare stocks in Aug 2026
      Sep 2Seeking AlphaLENZ

      This is the newest page. Registered accounts read further back.